Correction: Third conversion of convertibles in Smoltek completed - SEK 675 thousand converted into shares
4 augusti, 16:50
Correction: Third conversion of convertibles in Smoltek completed - SEK 675 thousand converted into shares
This press release is an English version of the previously published Swedish version, which has interpretive precedence.
An earlier version of this press release stated an incorrect conversion price. The correct conversion price is SEK 0.30 per share, not SEK 0.42 as previously stated. The correct information in full is provided below.
Smoltek Nanotech Holding AB (publ) (“Smoltek” or the “Company”) announces that a portion of the convertible loan with a nominal amount of SEK 20 million, which was issued in accordance with a resolution from the extraordinary general meeting on January 9, 2025, has been converted into shares in the Company. The total amount converted amounts to SEK 675 thousand. The conversion has been carried out in accordance with the established terms and conditions for the convertible loan.
A total of SEK 675,000 has been converted into shares in Smoltek, which results in an increase in the number of shares in the Company by 2,250,000 and an increase in the share capital by SEK 268,038.568023. After the conversion, the Company's share capital amounts to SEK 21,451,584.289639 and the number of shares in Smoltek to 180,071,342. The exact conversion rate for the convertible loans amounts to SEK 0.30 per share.
Convertible holders have the option to convert their convertibles into shares up to and including 31 January 2027. For conversions that occur after 31 January 2026, the conversion price will be increased by 10% to SEK 0.33 per share. After the maturity of the convertible loan, the right to convert will expire.
Smoltek Nanotech Holding is a deeptech company that provides a technology that enables the production of conductive nanostructures on various materials. The company's nanostructure manufacturing technology can be used in several industrial sectors. Customers are found in the global process industry and semiconductors. The products that the company develops are used in equipment to produce fossil-free hydrogen and in semiconductors to further miniaturize microchips. The company protects its unique carbon nanotechnology through an extensive patent portfolio consisting of more than 110 applied for patents, of which 96 are currently granted. Smoltek's share is listed on the Spotlight Stock Market under the ticker SMOL. Smoltek is a development company and forward-looking statements regarding time to market, production volume and price levels should be interpreted as forecasts and not commitments.
For further information:
Magnus Andersson, CEO of Smoltek Nanotech Holding AB
Email: magnus.andersson@smoltek.com
Phone: +46 317 01 03 05
Website: www.smoltek.com/investors
Ämnen i artikeln
Correction: Third conversion of convertibles in Smoltek completed - SEK 675 thousand converted into shares
4 augusti, 16:50
Correction: Third conversion of convertibles in Smoltek completed - SEK 675 thousand converted into shares
This press release is an English version of the previously published Swedish version, which has interpretive precedence.
An earlier version of this press release stated an incorrect conversion price. The correct conversion price is SEK 0.30 per share, not SEK 0.42 as previously stated. The correct information in full is provided below.
Smoltek Nanotech Holding AB (publ) (“Smoltek” or the “Company”) announces that a portion of the convertible loan with a nominal amount of SEK 20 million, which was issued in accordance with a resolution from the extraordinary general meeting on January 9, 2025, has been converted into shares in the Company. The total amount converted amounts to SEK 675 thousand. The conversion has been carried out in accordance with the established terms and conditions for the convertible loan.
A total of SEK 675,000 has been converted into shares in Smoltek, which results in an increase in the number of shares in the Company by 2,250,000 and an increase in the share capital by SEK 268,038.568023. After the conversion, the Company's share capital amounts to SEK 21,451,584.289639 and the number of shares in Smoltek to 180,071,342. The exact conversion rate for the convertible loans amounts to SEK 0.30 per share.
Convertible holders have the option to convert their convertibles into shares up to and including 31 January 2027. For conversions that occur after 31 January 2026, the conversion price will be increased by 10% to SEK 0.33 per share. After the maturity of the convertible loan, the right to convert will expire.
Smoltek Nanotech Holding is a deeptech company that provides a technology that enables the production of conductive nanostructures on various materials. The company's nanostructure manufacturing technology can be used in several industrial sectors. Customers are found in the global process industry and semiconductors. The products that the company develops are used in equipment to produce fossil-free hydrogen and in semiconductors to further miniaturize microchips. The company protects its unique carbon nanotechnology through an extensive patent portfolio consisting of more than 110 applied for patents, of which 96 are currently granted. Smoltek's share is listed on the Spotlight Stock Market under the ticker SMOL. Smoltek is a development company and forward-looking statements regarding time to market, production volume and price levels should be interpreted as forecasts and not commitments.
For further information:
Magnus Andersson, CEO of Smoltek Nanotech Holding AB
Email: magnus.andersson@smoltek.com
Phone: +46 317 01 03 05
Website: www.smoltek.com/investors
Ämnen i artikeln
Novo Nordisk
Aktieråd
-992x558.webp&w=3840&q=75)
Analys
Bostadsmarknaden
Novo Nordisk
Mest läst
Aktieråd
Analys
Bostadsmarknaden
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
